PTH-dependence of the effectiveness of cinacalcet in hemodialysis patients with secondary hyperparathyroidism

Cinacalcet lowers parathyroid hormone levels. Whether it can prolong survival of people with chronic kidney disease (CKD) complicated by secondary hyperparathyroidism (SHPT) remains controversial, in part because a recent randomized trial excluded patients with iPTH <300 pg/ml. We examined cinaca...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Sci Rep
Autores principales: Akizawa, Tadao, Kurita, Noriaki, Mizobuchi, Masahide, Fukagawa, Masafumi, Onishi, Yoshihiro, Yamaguchi, Takuhiro, Ellis, Alan R., Fukuma, Shingo, Alan Brookhart, M., Hasegawa, Takeshi, Kurokawa, Kiyoshi, Fukuhara, Shunichi
Formato: Artigo
Lenguaje:Inglês
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4829837/
https://ncbi.nlm.nih.gov/pubmed/27071541
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep19612
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares